• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养保健品在胰腺癌预防和治疗中的作用:靶向细胞信号传导、微小RNA和表观基因组。

The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.

作者信息

Li Yiwei, Go Vay Liang W, Sarkar Fazlul H

机构信息

From the *Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; †Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA; and ‡Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI.

出版信息

Pancreas. 2015 Jan;44(1):1-10. doi: 10.1097/MPA.0000000000000257.

DOI:10.1097/MPA.0000000000000257
PMID:25493373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4264839/
Abstract

Pancreatic cancer is one of the most aggressive malignancies in US adults. Experimental studies have found that antioxidant nutrients could reduce oxidative DNA damage, suggesting that these antioxidants may protect against pancreatic carcinogenesis. Several epidemiologic studies showed that dietary intake of antioxidants was inversely associated with the risk for pancreatic cancer, demonstrating the inhibitory effects of antioxidants on pancreatic carcinogenesis. Moreover, nutraceuticals, the anticancer agents from diet or natural plants, have been found to inhibit the development and progression of pancreatic cancer through the regulation of cellular signaling pathways. Importantly, nutraceuticals also up-regulate the expression of tumor-suppressive microRNAs (miRNAs) and down-regulate the expression of oncogenic miRNAs, leading to the inhibition of pancreatic cancer cell growth and pancreatic cancer stem cell self-renewal through modulation of cellular signaling network. Furthermore, nutraceuticals also regulate epigenetically deregulated DNAs and miRNAs, leading to the normalization of altered cellular signaling in pancreatic cancer cells. Therefore, nutraceuticals could have much broader use in the prevention and/or treatment of pancreatic cancer in combination with conventional chemotherapeutics. However, more in vitro mechanistic experiments, in vivo animal studies, and clinical trials are needed to realize the true value of nutraceuticals in the prevention and/or treatment of pancreatic cancer.

摘要

胰腺癌是美国成年人中侵袭性最强的恶性肿瘤之一。实验研究发现,抗氧化营养素可减少氧化性DNA损伤,这表明这些抗氧化剂可能预防胰腺癌的发生。多项流行病学研究表明,膳食中抗氧化剂的摄入量与患胰腺癌的风险呈负相关,证明了抗氧化剂对胰腺癌发生的抑制作用。此外,营养保健品,即来自饮食或天然植物的抗癌剂,已被发现可通过调节细胞信号通路来抑制胰腺癌的发展和进展。重要的是,营养保健品还上调肿瘤抑制性微小RNA(miRNA)的表达并下调致癌性miRNA的表达,通过调节细胞信号网络导致胰腺癌细胞生长和胰腺癌干细胞自我更新受到抑制。此外,营养保健品还可对表观遗传失调的DNA和miRNA进行调节,使胰腺癌细胞中改变的细胞信号正常化。因此,营养保健品与传统化疗药物联合使用在胰腺癌的预防和/或治疗中可能有更广泛的用途。然而,需要更多的体外机制实验、体内动物研究和临床试验来实现营养保健品在胰腺癌预防和/或治疗中的真正价值。

相似文献

1
The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.营养保健品在胰腺癌预防和治疗中的作用:靶向细胞信号传导、微小RNA和表观基因组。
Pancreas. 2015 Jan;44(1):1-10. doi: 10.1097/MPA.0000000000000257.
2
Developments in miRNA gene signaling pathways in pancreatic cancer.胰腺癌中miRNA基因信号通路的进展
Future Oncol. 2016 May;12(9):1135-50. doi: 10.2217/fon-2015-0050. Epub 2016 Mar 17.
3
MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer.胰腺癌的微小RNA靶向治疗方法
Int J Biol Sci. 2016 Jan 28;12(3):326-37. doi: 10.7150/ijbs.15017. eCollection 2016.
4
The epigenome and cancer prevention: A complex story of dietary supplementation.表观基因组与癌症预防:饮食补充的复杂故事。
Cancer Lett. 2014 Jan 28;342(2):275-84. doi: 10.1016/j.canlet.2012.01.021. Epub 2012 Jan 20.
5
Noncoding RNAs and pancreatic cancer.非编码RNA与胰腺癌
World J Gastroenterol. 2016 Jan 14;22(2):801-14. doi: 10.3748/wjg.v22.i2.801.
6
Epigenetic targeting in pancreatic cancer.胰腺癌的表观遗传学靶向治疗。
Cancer Treat Rev. 2014 Jun;40(5):656-64. doi: 10.1016/j.ctrv.2013.12.002. Epub 2014 Jan 3.
7
Dysregulation of key microRNAs in pancreatic cancer development.胰腺癌发生中关键 microRNAs 的失调。
Biomed Pharmacother. 2019 Jan;109:1008-1015. doi: 10.1016/j.biopha.2018.10.177. Epub 2018 Nov 6.
8
MicroRNA-gene signaling pathways in pancreatic cancer.胰腺癌中的微小RNA-基因信号通路
Biomed J. 2013 Sep-Oct;36(5):200-8. doi: 10.4103/2319-4170.119690.
9
Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.胰腺癌治疗的分子靶点:临床与实验研究
World J Gastroenterol. 2016 Jan 14;22(2):776-89. doi: 10.3748/wjg.v22.i2.776.
10
MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.微小 RNA 作为生物标志物及其在胰腺癌治疗中的应用前景。
Mol Cell Biochem. 2021 Dec;476(12):4191-4203. doi: 10.1007/s11010-021-04233-y. Epub 2021 Jul 29.

引用本文的文献

1
Isoflavones: Promising Natural Agent for Cancer Prevention and Treatment.异黄酮:癌症预防与治疗的有前景的天然药物
Food Sci Nutr. 2025 Mar 11;13(3):e70091. doi: 10.1002/fsn3.70091. eCollection 2025 Mar.
2
Interventions for Pancreatitis-New Approaches, Knowledge Gaps, and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.胰腺炎干预措施——新方法、知识空白和研究机会:美国国立糖尿病、消化和肾脏疾病研究所研讨会总结。
Pancreas. 2024 Apr 1;53(4):e368-e377. doi: 10.1097/MPA.0000000000002333. Epub 2024 Mar 13.
3
Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management.胰腺癌(胰腺导管腺癌):将循证补充措施引入综合临床管理
Cancers (Basel). 2020 Oct 23;12(11):3096. doi: 10.3390/cancers12113096.
4
Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway.Zyflamend 通过调节 JNK 通路诱导胰腺癌细胞凋亡。
Cell Commun Signal. 2020 Aug 14;18(1):126. doi: 10.1186/s12964-020-00609-7.
5
Epigenomics of Pancreatic Cancer: A Critical Role for Epigenome-Wide Studies.胰腺癌的表观基因组学:表观基因组范围研究的关键作用
Epigenomes. 2019 Mar;3(1). doi: 10.3390/epigenomes3010005. Epub 2019 Jan 19.
6
Dietary Compounds as Epigenetic Modulating Agents in Cancer.膳食化合物作为癌症中的表观遗传调节因子
Front Genet. 2019 Mar 1;10:79. doi: 10.3389/fgene.2019.00079. eCollection 2019.
7
Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin.胰腺癌的循证辅助治疗:对包括帕立骨化醇、羟氯喹、静脉注射维生素C、他汀类药物、二甲双胍、姜黄素和阿司匹林在内的辅助疗法的综述
Cancer Manag Res. 2018 Jul 13;10:2003-2018. doi: 10.2147/CMAR.S161824. eCollection 2018.
8
Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells.苦瓜汁通过靶向肿瘤细胞和肿瘤干细胞发挥其抗癌功效。
Mol Carcinog. 2018 Sep;57(9):1166-1180. doi: 10.1002/mc.22833. Epub 2018 May 18.
9
Cellular effects of a turmeric root and rosemary leaf extract on canine neoplastic cell lines.姜黄根和迷迭香叶提取物对犬肿瘤细胞系的细胞效应。
BMC Vet Res. 2017 Dec 13;13(1):388. doi: 10.1186/s12917-017-1302-2.
10
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.胰腺导管腺癌:当前及不断发展的治疗方法
Int J Mol Sci. 2017 Jun 22;18(7):1338. doi: 10.3390/ijms18071338.

本文引用的文献

1
Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.雷公藤红素通过 NF-κB 下调逆转缺氧诱导的胰腺癌上皮间质转化和干细胞样特征。
Int J Cancer. 2014 May 15;134(10):2489-503. doi: 10.1002/ijc.28583.
2
Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment.二甲双胍和阿司匹林通过靶向 AMPK-mTOR 和炎症预防和治疗胰腺癌的再利用。
Cancer Prev Res (Phila). 2014 Apr;7(4):388-97. doi: 10.1158/1940-6207.CAPR-13-0337. Epub 2014 Feb 11.
3
Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells.染料木黄酮通过调控胰腺癌细胞中的miR-27a来抑制细胞生长和侵袭。
Curr Pharm Des. 2014;20(33):5348-53. doi: 10.2174/1381612820666140128215756.
4
Kras as a key oncogene and therapeutic target in pancreatic cancer.Kras作为胰腺癌中的关键癌基因和治疗靶点。
Front Physiol. 2014 Jan 21;4:407. doi: 10.3389/fphys.2013.00407. eCollection 2013.
5
Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.异常DNA甲基转移酶表达在胰腺导管腺癌发生发展中的作用
J Exp Clin Cancer Res. 2013 Nov 5;32(1):86. doi: 10.1186/1756-9966-32-86.
6
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
7
mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions.mTOR通过特定的和与干性相关的功能在胰腺癌干细胞中发挥关键作用。
Sci Rep. 2013 Nov 15;3:3230. doi: 10.1038/srep03230.
8
Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.miR-221 的下调通过上调 PTEN、p27(kip1)、p57(kip2) 和 PUMA 抑制胰腺癌细胞的增殖。
Am J Cancer Res. 2013 Nov 1;3(5):465-77. eCollection 2013.
9
Biochanin A reduces pancreatic cancer survival and progression.大豆苷元 A 降低胰腺癌的存活率和进展。
Anticancer Drugs. 2014 Mar;25(3):296-302. doi: 10.1097/CAD.0000000000000044.
10
Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.胰腺炎-糖尿病-胰腺癌:NIDDK-NCI 研讨会综述。
Pancreas. 2013 Nov;42(8):1227-37. doi: 10.1097/MPA.0b013e3182a9ad9d.